NEUROONE MEDICAL TECHNOLOGIES Corp — Form 4
Filed September 8, 2026 · analyzed by the Insider Agent
4
▲ Likely positive
significance 52/100
What the filing says
Chief Business Officer Wambeke David J. (NMTC) bought 68K shares (~$67K) on the open market (66% of holdings). Open-market insider purchase — historically a bullish signal.
Why this rating
Open-market insider purchase — historically a bullish signal.
See more from September 8, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.